KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )

Go back to KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )
(NASDAQ: RXRX) Delayed: 2.96 -0.05 (1.66%)
Previous Close $3.01    52 Week High
Open $3.04    52 Week Low
Day High $3.09    P/E N/A 
Day Low $2.92    EPS
Volume 16,516,864